Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Status:
Terminated
Trial end date:
2017-06-11
Target enrollment:
Participant gender:
Summary
The primary goal of this study will be to examine tumor response after radiation treatment
via a combination of Samarium-153 EDTMP and external beam radiotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators:
Jazz Pharmaceuticals National Cancer Institute (NCI)